F Dx Advisors, Inc. Crispr Therapeutics Ag Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $16,915 - $31,614	438 Added 6.92%	6,766 $424,000
Q3 2023 Nov 02, 2023	SELL	$45.39 - $59.0 $79,387 - $103,191	-1,749 Reduced 21.65%	6,328 $287,000
Q2 2023 Jul 17, 2023	SELL	$43.47 - $67.77 $5,651 - $8,810	-130 Reduced 1.58%	8,077 $453,000
Q4 2022 Feb 09, 2023	SELL	$39.19 - $65.67 $71,169 - $119,256	-1,816 Reduced 18.12%	8,207 $334,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $28,839 - $39,544	-472 Reduced 4.5%	10,023 $655,000
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $82,007 - $140,055	1,897 Added 22.06%	10,495 $638,000
Q1 2022 May 03, 2022	BUY	$53.19 - $79.24 $79,785 - $118,859	1,500 Added 21.13%	8,598 $540,000
Q4 2021 Feb 01, 2022	BUY	$70.09 - $111.29 $71,001 - $112,736	1,013 Added 16.65%	7,098 $538,000
Q3 2021 Oct 08, 2021	BUY	$110.2 - $156.64 $36,035 - $51,221	327 Added 5.68%	6,085 $681,000
Q2 2021 Aug 05, 2021	SELL	$100.84 - $161.89 $126,554 - $203,171	-1,255 Reduced 17.9%	5,758 $932,000
Q1 2021 Apr 14, 2021	BUY	$110.72 - $210.04 $681,813 - $1.29 Million	6,158 Added 720.23%	7,013 $855,000
Q1 2021 Apr 13, 2021	SELL	$110.72 - $210.04 $916,761 - $1.74 Million	-8,280 Reduced 90.64%	855 $104,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $19,120 - $41,575	240 Added 2.7%	9,135 $1.4 Million
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $314,628 - $403,365	4,008 Added 82.01%	8,895 $744,000
Q2 2020 Jul 22, 2020	SELL	$38.5 - $76.05 $191,999 - $379,261	-4,987 Reduced 50.51%	4,887 $359,000
Q4 2018 Feb 07, 2019	BUY	$22.73 - $42.34 $224,436 - $418,065	9,874 New	9,874 $282,000

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$315 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$298 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$119 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$118 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$118 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account